(Q41552550)

3 October 2017

1 reference

title

Medical cardiovascular treatment trials: relevant to medical ophthalmology in 1997? (English)

1 reference

3 October 2017

Dodson PM

1

1 reference

3 October 2017

Kritzinger EE

series ordinal

2

1 reference

3 October 2017

publication date

1 January 1997

1 reference

3 October 2017

1 reference

3 October 2017

volume

11 ( Pt 1)

1 reference

3 October 2017

page(s)

3-11

1 reference

https://scigraph.springernature.com/pub.10.1038/eye.1997.2

3 October 2017

exact match

0 references

cites work

Prognosis and prognostic factors of retinal infarction: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Prognosis of patients with retinal embolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Prognostic factors for retinal vein occlusion: prospective study of 175 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FEYE.1997.2

21 January 2018

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

Medical conditions underlying recurrence of retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Duke-elder lecture. Systemic arterial blood pressure and the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Assessing possible hazards of reducing serum cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Cardiovascular disease in patients with retinal arterial occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Carotid endarterectomy in Great Britain and Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Carotid endarterectomy: recommendations for management of transient ischaemic attack and ischaemic stroke. Association of British Neurologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

Sex hormone preparations and retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

Diabetes mellitus and retinal vein occlusion in patients of Asian, west Indian and white European origin

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

Management of retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

Fibrinogen, cholesterol and smoking as risk factors for non-arteritic anterior ischaemic optic neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

Anterior ischemic optic neuropathy. VII. Incidence of bilaterality and various influencing factors

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive Type 1 (insulin-dependent) diabetic patients with background retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

Long-term follow-up of and underlying medical conditions in patients with diabetic exudative maculopathy

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

The effects of lipid lowering on diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

High systolic blood pressure increases prevalence and severity of retinopathy in NIDDM patients

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

Effects of long-term enalapril treatment on persistent microalbuminuria in normotensive type 2 diabetic patients: results of a 4-year, prospective, randomized study

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

https://api.crossref.org/works/10.1038%2FEYE.1997.2

1 reference

7 January 2021

Antithrombotic therapy in coronary artery disease.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

Streptokinase in central retinal vein occlusion: a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II)

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

Hormone replacement therapy and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.2

7 January 2021

Identifiers

DOI

10.1038/EYE.1997.2

1 reference

Dimensions Publication ID

3 October 2017

1000564927

0 references

1 reference